Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-076-8 | CAS number: 7785-23-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2016
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study without detailed documentation
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- According to OECD guideline for testing chemicals in toxicity studies in rodents (Guidelines for the Testing of Chemicals, Section.Health Effects. Test No. 408: Repeated dose 90-day oral toxicity study in rodents.) and NTP specification for the conduct of studies in laboratory animals NTP, 2011)
- Principles of method if other than guideline:
- The genotoxic effects of silver acetate exposure in mal and female rats were examined with a micronucleus assay, using flow cytometric analysis of peripheral blood (Witt et al., 2008). Blood obtained from the rat at week 1, 4 and 12 of the study were fixed in ultracold methanol and stored at -80°C until analysis for the frequency of micronucleated cells in 20,000 reticulocytes per samples.
- GLP compliance:
- yes
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- Silver acetate
- Cas Number:
- 563-63-3
- Molecular formula:
- AgC2H3O2
- IUPAC Name:
- Silver acetate
- Test material form:
- solid - liquid: suspension
Constituent 1
- Specific details on test material used for the study:
- Test item was purchased 99% pure as a single lot from Gelest, Inc. (Morrison, Pennsylvania), and batches of stock aqueous solutions (nominal concentration 10.4 mg/mL) were prepared in 18 megaohm and autoclave-sterilized water on an "as needed" or bi-weekly basis and stored at room temperature. Samples were submitted to inductively coupled mass spectrometry (ICP-MS) analysis to determine the actual silver mass concentrations. The test item solutions remained clear and colorless throughout the useful life of the solution of 2 weeks, indicating that the silver did not precipitate or become reduced.
Characterization of test item solutions:
Test material characterisation was conducted weekly at the National Center for Toxicology Research (NCTR) on freshly prepared test item solutions.
The samples were diluted to 50 mL with and acid mixture of 1 N each of nitric and hydrochloric acids.
For the stability study, total silver concentrations were determined by ICP-MS, initially for the test item stock suspensions and filtrates, and subsequently for filtrates collected from the same stock suspensions after storage in the dark at 4C–8C for 1 and 90 days. Homogeneity testing was conducted on test item stock suspensions from the same shipment as the stability study; however, triplicate subsamples were collected from the top, middle, and bottom of each vessel and analyzed in triplicate.
The average total silver concentrations by mass of the test item samples were determined with a Thermo Scientific WSERIES 2 Quadrupole ICP-MS (Franklin, Massachusetts), using 107Ag, 109Ag, and 103Rhodium (Rh) at 50 ng/ml and 115Indium (In) at 100 ng/ml as internal standards.
The concentration of Ag was quantified against an external calibration curve (NIST traceable silver samples). The limit of quantification (LOQ) for the test item suspensions and filtrates was estimated to be 40 ng/ml.
The identity of the test item was confirmed by 1H nuclear magnetic resonance spectroscopy on an AVANCE III spectrometer equipped with a BBFO Plus Smart Probe (Bruker Instruments, Billerica, Massachusetts) operating at 500 MHz. The samples were dissolved in D2O and the acquisition was conducted at room temperature using a standard 1H acquisition sequence.
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- - 3-week-old male and female Sprague Dawley/CD-23 rats with specific pathogen-free health status were obtained from the NCTR breeding colony.
- At 6 week of age, the rats were weight-ranked and randomly assigned to treatment groups. Male and female rat were housed conventionally in separate animal rooms with 2 animals per cage.
- The environment of the animal rooms was set to maintain a 12h light cycle, temperature of 22+/-4°C, relative humidity of 40%-70%, and air changes of 10-15 per hour.
- The animals were provided NIH-41 gamma-irradiated pellets and Millipore-filtered drinking water ad libitum.
- Rats were dosed initially at 7 weeks of age.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- Water/0.1% methyl cellulose, methylcellulose was used in this study as bulking agents to inhibit somewhat the gastroinstestinal passage of the mostly aqueous dose formulation. The compounds is not toxic and do not promote allergic reactions in rodents.
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Dose formulations were prepared weekly and were based on the total silver mass concentrations obtained by ICP-MS for silver acetate solution. The high-dose formulation of test item (10 mg AgAc/mL or approximately 6.46 mg Ag/mL) was prepared in water/0.1% methylcellulose (final concentration wt/wt).
- The silver concentration of the high-dose formulation were confirmed by ICP-MS and, then serially diluted in water/0.1% methylcellulose to achieve the 3.23 and 1.62 mg Ag/mL concentrations for the mid- and low-dose AgAc formulation respectivelly.
DOSE CHARACTERIZATION: The total silver concentration by mass of each of the prepared dose formulations (high-, mid-, and lowdose) and the controls ( water/MC) was determined by ICP-MS in acid- and microwave-digested samples. Characterization analyses were conducted on triplicate samples. Dose concentration acceptability was set at 610% targeted values.
VEHICLE
Methylcellulose was purchased from Fischer Scientific (Fair Lawn, New Jersey). The water used in dose formulations was 18 megaohm and autoclave-sterilized. - Duration of treatment / exposure:
- Groups of rats (10 males and 10 females) were exposed daily by oral gavage to dose formulation of AgAc at 100, 200 and 400 mg/kg bw or to the respective control formulations (Water/MC) for a period of 13 weeks.
- Frequency of treatment:
- Gavage dosing was conducted using computer-controlled MicroLabVR 500 series dispensers (Hamilton Co., Reno, Nevada) equipped with gastight syringes and capable of dispensing 1 ml to 50 ml. The syringes were fitted with flexible plastic gavage needles, and the rats were provided equal volume doses based on the daily body weight of the individual rats. The MicroLab dispensers were programmed to administer the total daily dose in 2 daily gavage administrations per day, with half of the dose administered at the start of the light cycle and half of the dose administered just prior to start of the dark cycle. The dose volumes did not exceed 20 ml/kg bw. Animals were dosed 7 days each week and the study period was 13 weeks.
- Post exposure period:
- none
Doses / concentrationsopen allclose all
- Dose / conc.:
- 100 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 200 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 400 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- 10 animals/sex/dose
- Control animals:
- yes, concurrent vehicle
Examinations
- Tissues and cell types examined:
- List of tissues examined:
- jejunum, ileum, colon, kidney, liver, spleen, - Details of tissue and slide preparation:
- At necropsy, organs and tissues were examined for grossly visible lesions, and protocol designated tissues and organs were weighed and preserved in 10% neutral buffered formalin (NBF), with the exception that modified Davidson’s fixative was used for the right testes and eyes. Femur bone marrow was collected for histopathology (left) and ICP-MS (right). The testes and epididymides were collected for sperm analysis (left) and histopathology (right). A section of the ileum and scrapping of the ileal mucosa were collected for intestinal microbiota and immune response evaluations (Williams et al., 2015). Sections
of the proximal ileum, jejunum, proximal colon, and mesenteric lymph nodes, the right kidney, median and left lateral liver lobes, and spleen were preserved for 2 weeks at 4°C in Karnovsky’s fixative and stored in 10% NBF at 4°C for TEM evaluations.
Additional sections of these organs and tissues, along with the heart and uterine horn, were collected, flash frozen in liquid nitrogen, and stored at 80°C for total silver analysis by ICP-MS. - Statistics:
- Micronuclei analysis was conducted for each sex using a 2-way fixed effect ANOVA to determine the effect of treatment using the arcsin square root transformation for percent data. Pairwise comparisons of the 2 control groups and each of the treatment groups to the appropriate control group were performed with Bonferroni adjustments. All tests were conducted as 2-sided with significance at the .05 probability level.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- ambiguous
- Remarks:
- high toxicity level
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Remarks on result:
- other: 400 mg/kg bw/d small but significant increase in the frequency of micronucleated reticulocytes at week-4, but not subsequent time point. Those animals had severe gastroinestinal distress and only 1 female and no male rats survived to week 12
Applicant's summary and conclusion
- Conclusions:
- Male and female rats administered with 400 mg/kg bw/day (highest dose) had a small but significant increase in frequency of micronucleated reticulocytes at week-4 only, but not at subsequent time points. In addition, these animals had severe gastrointestinal distress and only 1 female and no male rats survived to week 12.
In conclusion, under the study conditions, silver acetate do not induce micronuclei in reticulocytes of female and male rats. - Executive summary:
The genotoxic effects of silver acetate exposure in mal and female rats were examined with a micronucleus assay, using flow cytometric analysis of peripheral blood (Witt et al., 2008). Blood obtained from the rat at week 1, 4 and 12 of the study were fixed in ultracold methanol and stored at -80°C until analysis for the frequency of micronucleated cells in 20,000 reticulocytes per samples.
Male and female rats administered with 400 mg/kg bw/day (highest dose) had a small but significant increase in frequency of micronucleated reticulocytes at week-4 only, but not at subsequent time points. In addition, these animals had severe gastrointestinal distress and only 1 female and no male rats survived to week 12.
In conclusion, under the study conditions, silver acetate do not induce micronuclei in reticulocytes of female and male rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.